Christophe Arbet Engels X4 Pharmaceuticals, Inc (XFOR) insider trading activity

XFOR Quotes by TradingView

Christophe Arbet Engels is Chief Medical Officer of X4 Pharmaceuticals, Inc. Currently has a direct ownership of 864,207 shares of XFOR, which is worth approximately $1.28 Million. The most recent transaction as insider was on Feb 12, 2025, when has been sold 850,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 864K
0% 3M change
n/a 12M change
Total Value Held $1.28 Million

Christophe Arbet-Engels Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 12 2025
BUY
Grant, award, or other acquisition
-
850,000 Added 49.59%
864,207 Common Stock
Jan 24 2025
SELL
Open market or private sale
$5,230 $0.45 p/Share
11,624 Reduced 45.0%
14,207 Common Stock
Jan 23 2025
BUY
Grant, award, or other acquisition
-
25,831 Added 50.0%
25,831 Common Stock
CA

Christophe Arbet Engels

Chief Medical Officer
Boston, MA

Track Institutional and Insider Activities on XFOR

Follow X4 Pharmaceuticals, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XFOR shares.

Notify only if

Insider Trading

Get notified when an X4 Pharmaceuticals, Inc insider buys or sells XFOR shares.

Notify only if

News

Receive news related to X4 Pharmaceuticals, Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XFOR